Often used for neuroprotection and cognitive aging, its a great option for busy minds or aging brains
This progression is similar to what researchers observe with the GLP-1 onset timeline across all medications in this class
Despite the diversity in neurodegenerative diseases, there is a common theme among them: a synergy between mitochondria and microbiota early in life is sooner or later disturbed and, late in life, turned into its very opposite
Weeks 8-12: Visible Results Phase Leaner overall appearance Improved muscle tone and definition Measurable reduction in abdominal fat Better mood stability and motivation More stable energy throughout the day Improved exercise performance metrics Months 3-6: Optimization Phase Continued improvements in lean body mass Further reductions in body fat percentage Enhanced immune function and fewer minor illnesses Improved cholesterol and metabolic markers Sustained energy and vitality improvements Potential improvements in hair and nail quality Research by Vittone et al
Curr Drug Targets CNS Neurol Disord 4 , 657665 (2005)
4.3 Clinical translation and integration with western medicine The ultimate challenge is translating promising natural metabolites into approved, widely adopted therapies
